All posts tagged
Swiss Genomics Firm, Biogen and Microsoft Team Up to Treat Multiple Sclerosis
German Biotech Unveils Positive Phase II Results for Alzheimer’s
How Biotech is Mastering Multiple Sclerosis: A Review
Following Eli Lilly’s Failure, what’s Next in Alzheimer’s Treatments?
Interview: GeNeuro’s CFO explains its Unique Multiple Sclerosis Treatment
Rare Disease Biopharma can now sell Hemophilia treatment across whole of EU
Sanofi-Genzyme: Still successful 5 years after the acquisition?
Also Using PD-L1 Cancer Treatments to Attack Alzheimer’s Disease
Epigenetics Baby of Proteros is Signing Up with Top US Neurology Specialists
Dementia could bankrupt us all… The Biotech ‘A’ Team comes to the rescue!
Global Hemophilia AID project achieves first milestone with donations from Swedish Biotech
The 5 things outside Europe you need to know this week (Samsung $1Bn Biotech IPO, Microbiome blindness, Google Biotech)
Labiotech UG, All Rights Reserved -
Send this to a friend